Find an Article

Filter articles

Applied Filters

Showing 101 to 110 of 279 results

Fertile ground for innovators

Mexico26-10-2017Eder Gutiérrez

Owners of biotech inventions may find Mexico an attractive country in which to apply for patent protection because of its non-restrictive patent law and its practical approach to examination, as Eder Gutiérrez of Clarke Modet & Co outlines.

Raising the plausibility bar

EU26-10-2017David Carling and Richard Wells

Patent applicants have long wrestled with the question of how much experimental evidence to include in a new patent application. David Carling and Richard Wells of Potter Clarkson examine the issue in Europe.

Plausibility: How much information is enough?

EU24-10-2017Iain Armstrong

Patentees should ensure their applications meet the plausibility standard right from the start, says Iain Armstrong of HGF, who investigates one of the developing challenges facing patentability in the life sciences field.

A vitally important innovative tool

Brazil24-10-2017Gabriel Di Blasi

If biotech companies in Brazil understand that they can use both plant variety and patent protection in certain cases, their ability to innovate may improve, says Gabriel Di Blasi of Di Blasi, Parente & Associados.

Precision medicine: getting patenting spot on

US12-07-2017Sheena Linehan

Precision medicine has come a long way since the completion of the Human Genome Project in 2003, but how have IP regimes developed in this area, asks Sheena Linehan of Potter Clarkson.

Advertising in Mexico: it pays to check your copy


An advice system for labelling products in Mexico has been extended to food and non-alcoholic beverages. Daniel Sanchez and Victor Ramirez of Olivares report on how the regime works in practice.

CRISPR in Europe: priority becomes just that at the EPO


The formal requirements for priority have become a hot topic at the European Patent Office, driven by their importance in high-profile oppositions to the Broad Institute’s CRISPR/Cas9 patents, as Catherine Coombes of HGF explains.

ANVISA and INPI: the end of an impasse?

Brazil25-04-2017Breno Souza, Luisa Rezende and Silvia Costa

A disagreement over how pharma patents in Brazil are examined seems to have come to an end, as Breno Souza, Luisa Rezende and Silvia Costa of Clarke Modet & Co Brazil report.

Plants, patents and political challenges

EU04-04-2017Jane Wainwright

European developments surrounding the patentability of plants and animals have become rather political, but there are ways for patentees to mitigate the effects of political influence over the patenting process, writes Jane Wainwright of Potter Clarkson.

New rules for SPCs in Spain

Spain27-03-2017José Manuel González

A new law on supplementary protection certificates will be implemented on April 1, with the application, prosecution and maintenance of SPCs taking centre stage. José Manuel González of Clarke, Modet & Co reports.

Showing 101 to 110 of 279 results